A Single Botulinum Toxin Injection in the Treatment of Strabismus: A Retrospective Analysis of 29 Patients

Q4 Medicine Jordan Medical Journal Pub Date : 2022-07-31 DOI:10.35516/jmj.v56i2.242
R. Shatnawi
{"title":"A Single Botulinum Toxin Injection in the Treatment of Strabismus: A Retrospective Analysis of 29 Patients","authors":"R. Shatnawi","doi":"10.35516/jmj.v56i2.242","DOIUrl":null,"url":null,"abstract":"Objective: To describe the change in angle deviation, treatment effectiveness, overall safety, and cost effectiveness of the use of a single botulinum toxin injection session in the treatment of strabismus.Methods: A retrospective analysis at a tertiary hospital in Amman, Jordan, to identify 29 patients who received a single botulinum toxin injection as a treatment of strabismus between October 2017 and March 2019. The outcome was determined by the improvement of the angle of deviation and avoidance of conventional muscle surgery. The safety profile was determined according to the incidence of adverse effects,such as overcorrection and ptosis. The economic profile included the medical and non-medical costs.Results: The average of the total angles of deviation for the whole group improved in the first assessment visit in the first week post injection from 38.97 to 19.48 prism diopter (PD). However, the deviation started to increase after the first month and continued to increase, reaching 27.93 PD in the sixth month post injection follow up. About five of the 29 patients (17.2%) had a successful outcome (angle of deviation equal to or less than 10 PD) in the sixth month post injection, while around seven of the 29 patients (24.1%) had a partial improvement and 17 of the 29 patients (58.7%) had no improvement. Only two patients (6.8%) developed overcorrection. None of the patients developed ptosis or other adverse effects after injection. The total average cost of treatment, including medical and non-medical costs, was $410. The average medical cost was $305, while the non-medical cost was $105. Conclusion: The use of a single botulinum toxin injection for treating strabismus is an effective, safe, and quick procedure to treat strabismus in some patients, especially those with mild and moderate angles of deviation. However, due to the temporary effect of the drug, it needs to be repeated for some patients and thus may be unsatisfactory in some circumstances.","PeriodicalId":39681,"journal":{"name":"Jordan Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jordan Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35516/jmj.v56i2.242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To describe the change in angle deviation, treatment effectiveness, overall safety, and cost effectiveness of the use of a single botulinum toxin injection session in the treatment of strabismus.Methods: A retrospective analysis at a tertiary hospital in Amman, Jordan, to identify 29 patients who received a single botulinum toxin injection as a treatment of strabismus between October 2017 and March 2019. The outcome was determined by the improvement of the angle of deviation and avoidance of conventional muscle surgery. The safety profile was determined according to the incidence of adverse effects,such as overcorrection and ptosis. The economic profile included the medical and non-medical costs.Results: The average of the total angles of deviation for the whole group improved in the first assessment visit in the first week post injection from 38.97 to 19.48 prism diopter (PD). However, the deviation started to increase after the first month and continued to increase, reaching 27.93 PD in the sixth month post injection follow up. About five of the 29 patients (17.2%) had a successful outcome (angle of deviation equal to or less than 10 PD) in the sixth month post injection, while around seven of the 29 patients (24.1%) had a partial improvement and 17 of the 29 patients (58.7%) had no improvement. Only two patients (6.8%) developed overcorrection. None of the patients developed ptosis or other adverse effects after injection. The total average cost of treatment, including medical and non-medical costs, was $410. The average medical cost was $305, while the non-medical cost was $105. Conclusion: The use of a single botulinum toxin injection for treating strabismus is an effective, safe, and quick procedure to treat strabismus in some patients, especially those with mild and moderate angles of deviation. However, due to the temporary effect of the drug, it needs to be repeated for some patients and thus may be unsatisfactory in some circumstances.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肉毒杆菌毒素单次注射治疗斜视29例回顾性分析
目的:描述单次肉毒杆菌毒素注射治疗斜视在角度偏差、治疗有效性、总体安全性和成本效益方面的变化。方法:在约旦安曼的一家三级医院进行回顾性分析,以确定2017年10月至2019年3月期间接受单一肉毒杆菌毒素注射治疗斜视的29名患者。结果取决于偏离角度的改善和传统肌肉手术的避免。根据不良反应的发生率来确定安全性,如矫正过度和上睑下垂。经济概况包括医疗和非医疗费用。结果:在注射后第一周的第一次评估访视中,整个组的总偏转角平均值从38.97提高到19.48棱镜屈光度(PD)。然而,偏差在第一个月后开始增加,并继续增加,在注射后的第六个月随访中达到27.93 PD。29名患者中约有5名(17.2%)在注射后第6个月取得了成功(偏离角等于或小于10 PD),而29名患者约有7名(24.1%)部分改善,29名患者有17名(58.7%)没有改善。只有两名患者(6.8%)出现过度矫正。注射后,没有患者出现上睑下垂或其他不良反应。包括医疗和非医疗费用在内的平均治疗费用总额为410美元。平均医疗费用为305美元,而非医疗费用为105美元。结论:单次肉毒杆菌毒素注射治疗斜视是一种有效、安全、快速的手术方法,可治疗部分患者的斜视,尤其是轻度和中度斜视患者。然而,由于药物的暂时作用,需要对一些患者重复使用,因此在某些情况下可能不令人满意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Jordan Medical Journal
Jordan Medical Journal Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
33
期刊最新文献
Hirschsprung Disease in Jordan: A Review and Status Update Poison Centers in the Eastern Mediterranean Region: History, Scope of Services, and Strengths and Weaknesses as Public Healthcare Providers Mediastinal Bronchogenic Cysts: Clinical Presentation, Diagnosis, and Treatment Outcomes Safety and Efficacy of Bone Marrow and Adipose Tissue Mesenchymal Stem Cells in the Treatment of Spinal Cord Injury: A Preliminary Study Irisin’s Mechanism of Action and Levels in Physiological and Pathological Conditions
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1